NG
Therapeutic Areas
Lupin Limited Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Generic Spiriva (Tiotropium) | COPD | Approved |
| Generic ProAir (Albuterol HFA) | Asthma/COPD | Approved |
| Generic Advair (Fluticasone/Salmeterol) | Asthma/COPD | Phase 3 |
| Ethinyl Estradiol/Norgestimate | Oral Contraceptive | Approved |
| Levothyroxine Sodium | Hypothyroidism | Approved |
| Generic Suprep | Bowel Preparation | Approved |
| Methylphenidate ER | ADHD | Approved |
| Generic Symbicort | Asthma/COPD | Development |
Leadership Team at Lupin Limited
VG
Vinita Gupta
CEO
RS
Ramesh Swaminathan
Executive Director & Global CFO
RS
Rajeev Sibal
President - India Region Formulations
FE
Fabrice Egros
President & CEO - North America
CK
Cyrus Karkaria
President - Global API
AS
Alok Sonig
Executive Vice President - Global Biosimilars